Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021HekaBio2021年10月12日読了時間: 1分更新日：9月4日Read the press release from here
Indonesia Inovasi Sehat and HekaBio Sign Strategic Agreement to Advance Healthcare Innovation in Indonesia Oct 1, 2025
